Literature DB >> 29449492

Structures of C1-IgG1 provide insights into how danger pattern recognition activates complement.

Deniz Ugurlar1, Stuart C Howes2, Bart-Jan de Kreuk3, Roman I Koning2,4, Rob N de Jong3, Frank J Beurskens3, Janine Schuurman3, Abraham J Koster2,4, Thomas H Sharp5, Paul W H I Parren6,7, Piet Gros8.   

Abstract

Danger patterns on microbes or damaged host cells bind and activate C1, inducing innate immune responses and clearance through the complement cascade. How these patterns trigger complement initiation remains elusive. Here, we present cryo-electron microscopy analyses of C1 bound to monoclonal antibodies in which we observed heterogeneous structures of single and clustered C1-immunoglobulin G1 (IgG1) hexamer complexes. Distinct C1q binding sites are observed on the two Fc-CH2 domains of each IgG molecule. These are consistent with known interactions and also reveal additional interactions, which are supported by functional IgG1-mutant analysis. Upon antibody binding, the C1q arms condense, inducing rearrangements of the C1r2s2 proteases and tilting C1q's cone-shaped stalk. The data suggest that C1r may activate C1s within single, strained C1 complexes or between neighboring C1 complexes on surfaces.
Copyright © 2018 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29449492     DOI: 10.1126/science.aao4988

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  51 in total

Review 1.  Clinical promise of next-generation complement therapeutics.

Authors:  Dimitrios C Mastellos; Daniel Ricklin; John D Lambris
Journal:  Nat Rev Drug Discov       Date:  2019-07-19       Impact factor: 84.694

2.  Structure of a Therapeutic Full-Length Anti-NPRA IgG4 Antibody: Dissecting Conformational Diversity.

Authors:  Michaela Blech; Stefan Hörer; Alexander B Kuhn; Sebastian Kube; Hendrik Göddeke; Hans Kiefer; Yuguo Zang; Yannic Alber; Stefan M Kast; Martin Westermann; Mark D Tully; Lars V Schäfer; Patrick Garidel
Journal:  Biophys J       Date:  2019-04-05       Impact factor: 4.033

3.  The solution structure of the human IgG2 subclass is distinct from those for human IgG1 and IgG4 providing an explanation for their discrete functions.

Authors:  Gar Kay Hui; Antoni D Gardener; Halima Begum; Charles Eldrid; Konstantinos Thalassinos; Jayesh Gor; Stephen J Perkins
Journal:  J Biol Chem       Date:  2019-05-14       Impact factor: 5.157

4.  Antigen-Induced Allosteric Changes in a Human IgG1 Fc Increase Low-Affinity Fcγ Receptor Binding.

Authors:  Chiara Orlandi; Daniel Deredge; Krishanu Ray; Neelakshi Gohain; William Tolbert; Anthony L DeVico; Patrick Wintrode; Marzena Pazgier; George K Lewis
Journal:  Structure       Date:  2020-03-24       Impact factor: 5.006

Review 5.  Antibody-mediated complement activation in pathology and protection.

Authors:  Benjamin S Goldberg; Margaret E Ackerman
Journal:  Immunol Cell Biol       Date:  2020-04-06       Impact factor: 5.126

6.  Engineering the Human Fc Region Enables Direct Cell Killing by Cancer Glycan-Targeting Antibodies without the Need for Immune Effector Cells or Complement.

Authors:  Mireille Vankemmelbeke; Richard S McIntosh; Jia Xin Chua; Thomas Kirk; Ian Daniels; Marilena Patsalidou; Robert Moss; Tina Parsons; David Scott; Gemma Harris; Judith M Ramage; Ian Spendlove; Lindy G Durrant
Journal:  Cancer Res       Date:  2020-06-12       Impact factor: 12.701

Review 7.  A synopsis of recent developments defining how N-glycosylation impacts immunoglobulin G structure and function.

Authors:  Yoshiki Yamaguchi; Adam W Barb
Journal:  Glycobiology       Date:  2020-03-20       Impact factor: 4.313

8.  IgG3 regulates tissue-like memory B cells in HIV-infected individuals.

Authors:  Lela Kardava; Haewon Sohn; Christine Youn; James W Austin; Wei Wang; Clarisa M Buckner; J Shawn Justement; Valerie A Melson; Gwynne E Roth; Marissa A Hand; Kathleen R Gittens; Richard W Kwan; Michael C Sneller; Yuxing Li; Tae-Wook Chun; Peter D Sun; Susan K Pierce; Susan Moir
Journal:  Nat Immunol       Date:  2018-08-13       Impact factor: 25.606

Review 9.  New insights into the immune functions of complement.

Authors:  Edimara S Reis; Dimitrios C Mastellos; George Hajishengallis; John D Lambris
Journal:  Nat Rev Immunol       Date:  2019-08       Impact factor: 53.106

10.  Designed proteins assemble antibodies into modular nanocages.

Authors:  Robby Divine; Ha V Dang; George Ueda; Jorge A Fallas; Ivan Vulovic; William Sheffler; Shally Saini; Yan Ting Zhao; Infencia Xavier Raj; Peter A Morawski; Madeleine F Jennewein; Leah J Homad; Yu-Hsin Wan; Marti R Tooley; Franziska Seeger; Ali Etemadi; Mitchell L Fahning; James Lazarovits; Alex Roederer; Alexandra C Walls; Lance Stewart; Mohammadali Mazloomi; Neil P King; Daniel J Campbell; Andrew T McGuire; Leonidas Stamatatos; Hannele Ruohola-Baker; Julie Mathieu; David Veesler; David Baker
Journal:  Science       Date:  2021-04-02       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.